Cargando…

Imipenem resistance of Pseudomonas in pneumonia: a systematic literature review

BACKGROUND: Pneumonia, and particularly nosocomial (NP) and ventilator-associated pneumonias (VAP), results in high morbidity and costs. NPs in particular are likely to be caused by Pseudomonas aeruginosa (PA), ~20% of which in observational studies are resistant to imipenem. We sought to identify t...

Descripción completa

Detalles Bibliográficos
Autores principales:	Zilberberg, Marya D, Chen, Joyce, Mody, Samir H, Ramsey, Andrew M, Shorr, Andrew F
Formato:	Texto
Lenguaje:	English
Publicado:	BioMed Central 2010
Materias:	Research Article
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC2939581/ https://www.ncbi.nlm.nih.gov/pubmed/20796312 http://dx.doi.org/10.1186/1471-2466-10-45

Ejemplares similares

Outcomes associated with bacteremia in the setting of methicillin-resistant Staphylococcus aureus pneumonia: a retrospective cohort study
por: Shorr, Andrew F., et al.
Publicado: (2015)

Multidrug resistance, inappropriate empiric therapy, and hospital mortality in Acinetobacter baumannii pneumonia and sepsis
por: Zilberberg, Marya D., et al.
Publicado: (2016)

Viruses are prevalent in non-ventilated hospital-acquired pneumonia
por: Shorr, Andrew F., et al.
Publicado: (2017)

Carbapenem resistance, inappropriate empiric treatment and outcomes among patients hospitalized with Enterobacteriaceae urinary tract infection, pneumonia and sepsis
por: Zilberberg, Marya D., et al.
Publicado: (2017)

1314. Descriptive Epidemiology of 30-day Readmissions among Survivors of Hospitalization with Bacterial Nosocomial Pneumonia in the US, 2012-2019
por: Zilberberg, Marya, et al.
Publicado: (2021)

Azithromycin and survival in Streptococcus pneumoniae pneumonia: a retrospective study
por: Shorr, Andrew F, et al.
Publicado: (2013)

Growth and Geographic Variation in Hospitalizations with Resistant Infections, United States, 2000–2005
por: Zilberberg, Marya D., et al.
Publicado: (2008)

Descriptive epidemiology of hospitalized patients with bacterial nosocomial pneumonia who experience 30-day readmission in the US, 2014–2019
por: Zilberberg, Marya D., et al.
Publicado: (2022)

Prolonged acute mechanical ventilation and hospital bed utilization in 2020 in the United States: implications for budgets, plant and personnel planning
por: Zilberberg, Marya D, et al.
Publicado: (2008)

Effect of a restrictive transfusion strategy on transfusion-attributable severe acute complications and costs in the US ICUs: a model simulation
por: Zilberberg, Marya D, et al.
Publicado: (2007)

Impact of prior probabilities of MRSA as an infectious agent on the accuracy of the emerging molecular diagnostic tests: a model simulation
por: Zilberberg, Marya D, et al.
Publicado: (2012)

Statistics on steroids: How recognizing competing risks gets us closer to the truth about COVID-19-associated VAP
por: Shorr, Andrew F., et al.
Publicado: (2022)

Descriptive Epidemiology and Outcomes of Nonventilated Hospital-Acquired, Ventilated Hospital-Acquired, and Ventilator-Associated Bacterial Pneumonia in the United States, 2012–2019
por: Zilberberg, Marya D., et al.
Publicado: (2021)

Genomic Characterization of Imipenem- and Imipenem-Relebactam-Resistant Clinical Isolates of Pseudomonas aeruginosa
por: López-Pérez, Mario, et al.
Publicado: (2021)

Inappropriate Empiric Therapy Impacts Complications and Hospital Resource Utilization Differentially Among Different Types of Bacterial Nosocomial Pneumonia: A Cohort Study, United States, 2014–2019
por: Zilberberg, Marya D., et al.
Publicado: (2022)

30-day readmission, antibiotics costs and costs of delay to adequate treatment of Enterobacteriaceae UTI, pneumonia, and sepsis: a retrospective cohort study
por: Zilberberg, Marya D., et al.
Publicado: (2017)

Daily cost of delay to adequate antibiotic treatment among patients surviving a hospitalization with community-onset Acinetobacter baumannii pneumonia or sepsis
por: Zilberberg, Marya D., et al.
Publicado: (2017)

Multiple antimicrobial resistance and outcomes among hospitalized patients with complicated urinary tract infections in the US, 2013–2018: a retrospective cohort study
por: Zilberberg, Marya D., et al.
Publicado: (2021)

Mechanisms of Heteroresistance and Resistance to Imipenem in Pseudomonas aeruginosa
por: Xu, Ye, et al.
Publicado: (2020)

Upstream region of OprD mutations in imipenem-resistant and imipenem-sensitive Pseudomonas isolates
por: Kiani, Masoumeh, et al.
Publicado: (2021)

Cost-effectiveness of micafungin as an alternative to fluconazole empiric treatment of suspected ICU-acquired candidemia among patients with sepsis: a model simulation
por: Zilberberg, Marya D, et al.
Publicado: (2009)

Increase in Adult Clostridium difficile–related Hospitalizations and Case-Fatality Rate, United States, 2000–2005
por: Zilberberg, Marya D., et al.
Publicado: (2008)

Imipenem Resistant Pseudomonas aeruginosa: The fall of the final quarterback
por: Ameen, Nadya, et al.
Publicado: (2015)

1461. Antimicrobial Susceptibility Patterns of Common Complicated Urinary Tract Infection Pathogens in US Hospitals, 2013–2018
por: Zilberberg, Marya, et al.
Publicado: (2019)

1455. Epidemiology, Empiric Treatment, and Outcomes Among Hospitalized Patients With Complicated Urinary Tract Infections in the United States, 2013–2018
por: Zilberberg, Marya, et al.
Publicado: (2019)

1430. Descriptive Epidemiology of Emergency Department Visits with cUTI in the US, 2012-2018
por: Zilberberg, Marya, et al.
Publicado: (2021)

Hyponatremia and hospital outcomes among patients with pneumonia: a retrospective cohort study
por: Zilberberg, Marya D, et al.
Publicado: (2008)

The risk of inappropriate empiric treatment and its outcomes based on pathogens in non-ventilated (nvHABP), ventilated (vHABP) hospital-acquired and ventilator-associated (VABP) bacterial pneumonia in the US, 2012–2019
por: Zilberberg, Marya D., et al.
Publicado: (2022)

Multi-drug resistance, inappropriate initial antibiotic therapy and mortality in Gram-negative severe sepsis and septic shock: a retrospective cohort study
por: Zilberberg, Marya D, et al.
Publicado: (2014)

Predictors of hospital mortality among septic ICU patients with Acinetobacter spp.bacteremia: a cohort study
por: Shorr, Andrew F, et al.
Publicado: (2014)

Descriptive epidemiology and outcomes of emergency department visits with complicated urinary tract infections in the United States, 2016–2018
por: Zilberberg, Marya D., et al.
Publicado: (2022)

Descriptive Epidemiology and Outcomes of Hospitalizations With Complicated Urinary Tract Infections in the United States, 2018
por: Zilberberg, Marya D, et al.
Publicado: (2022)

Time Trends in the Burden of Hospitalizations with Invasive Aspergillosis in the United States, 2004–2013
por: Zilberberg, Marya D, et al.
Publicado: (2017)

718 Predictors of Hospital Mortality Among Septic ICU Patients With Acinetobacter spp. Bacteremia: A Cohort Study
por: Shorr, Andrew F., et al.
Publicado: (2014)

1658 C. difficile Recurrence is a Strong Predictor of 30-day Rehospitalization Among ICU Patients
por: Zilberberg, Marya D., et al.
Publicado: (2014)

Imipenem-Resistant Pseudomonas aeruginosa: Risk Factors for Nosocomial Infections
por: Onguru, Pinar, et al.
Publicado: (2008)

Epidemiology of VIM-1-imipenem resistant Pseudomonas aeruginosa in Iran: A systematic review and meta-analysis
por: Sedighi, Mansour, et al.
Publicado: (2014)

Burden of hospitalizations over time with invasive aspergillosis in the United States, 2004–2013
por: Zilberberg, Marya D., et al.
Publicado: (2019)

Current Epidemiology, Etiology, and Burden of Acute Skin Infections in the United States
por: Kaye, Keith S, et al.
Publicado: (2019)

No Development of Imipenem Resistance in Pneumonia Caused by Escherichia coli
por: Yayan, Josef, et al.
Publicado: (2015)

Cannot write session to /tmp/vufind_sessions/sess_ctbuhmn1dj663fudvo0b33uta7